Nanomedicine for the prevention, treatment and imaging of atherosclerosis.

Nanomedicine for the prevention, treatment and imaging of atherosclerosis.

Show other versions (2)

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in developed countries, with an increasing prevalence due to an aging population. The pathology underpinning CVD is atherosclerosis, a chronic inflammatory state involving the arterial wall. Accumulation of low density lipo...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Psarros, C, Lee, R, Margaritis, M, Antoniades, C
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2012

Eitemau Tebyg

Nanomedicine for the prevention, treatment and imaging of atherosclerosis
gan: Psarros, C, et al.
Cyhoeddwyd: (2012)

Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
gan: Psarros, C, et al.
Cyhoeddwyd: (2012)

Nanomedicine for Diagnosis and Treatment of Atherosclerosis
gan: Jingyun Cheng, et al.
Cyhoeddwyd: (2023-12-01)

Construction of dual nanomedicines for the imaging and alleviation of atherosclerosis
gan: Shuihua Zhang, et al.
Cyhoeddwyd: (2020-01-01)

Nanomedicine-based drug delivery strategies for the treatment of atherosclerosis
gan: Yongfang Lin, et al.
Cyhoeddwyd: (2024-06-01)

The role of adiponectin at different stages of atherosclerosis in heart failure: associations with myocardial redox state
gan: Antonopoulos, A, et al.
Cyhoeddwyd: (2010)

Nanoparticles: a promising therapeutic approach in atherosclerosis.
gan: Antoniades, C, et al.
Cyhoeddwyd: (2010)

Biomimetic nanomedicines for precise atherosclerosis theranostics
gan: Ying Tao, et al.
Cyhoeddwyd: (2023-11-01)

Editorial: Advances on targeted nanomedicines for atherosclerosis
gan: Qinggong Han, et al.
Cyhoeddwyd: (2022-10-01)

Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis
gan: Ping Ping Hu, et al.
Cyhoeddwyd: (2022-09-01)

Novel therapeutic strategies targeting vascular redox in human atherosclerosis.
gan: Antonopoulos, A, et al.
Cyhoeddwyd: (2009)

Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications
gan: Xue Li, et al.
Cyhoeddwyd: (2022-10-01)

Statin treatment improves vascular redox state through a tetrahydrobiopterin-mediated re-coupling of endothelial nitric oxide synthase, in human atherosclerosis
gan: Antoniades, C, et al.
Cyhoeddwyd: (2011)

Precision nanomedicine in atherosclerosis therapy: how far are we from reality?
gan: Yee Shan Wong, et al.
Cyhoeddwyd: (2019-01-01)

Multifunctional phototheranostic nanomedicine for cancer imaging and treatment
gan: D. Gao, et al.
Cyhoeddwyd: (2020-01-01)

Interrelationships between vascular superoxide and adiponectin biosynthesis in perivascular adipose tissue in human atherosclerosis
gan: Bakogiannis, C, et al.
Cyhoeddwyd: (2010)

Shedding new light on atherosclerosis therapeutics: Nanomedicines targeting atherosclerotic immune microenvironment
gan: Zhiyue Wang, et al.
Cyhoeddwyd: (2024-12-01)

Nanomedicine for renal cell carcinoma: imaging, treatment and beyond
gan: Ruolin Wu, et al.
Cyhoeddwyd: (2023-01-01)

Adiponectin as a regulator of vascular redox state in human atherosclerosis
gan: Margaritis, M
Cyhoeddwyd: (2016)

Macrophage-targeting Antisenescence nanomedicine enables in-Situ NO induction for Gaseous and antioxidative atherosclerosis intervention
gan: Yuanyuan Peng, et al.
Cyhoeddwyd: (2025-06-01)

L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
gan: Siasos, G, et al.
Cyhoeddwyd: (2007)

A novel cross-talk between perivascular adipose tissue and the arterial wall controls redox state in human atherosclerosis
gan: Margaritis, M, et al.
Cyhoeddwyd: (2013)

A NOVEL CROSS-TALK BETWEEN PERIVASCULAR ADIPOSE TISSUE AND THE ARTERIAL WALL CONTROLS REDOX STATE IN HUMAN ATHEROSCLEROSIS
gan: Margaritis, M, et al.
Cyhoeddwyd: (2013)

Macrophage membrane-functionalized manganese dioxide nanomedicine for synergistic treatment of atherosclerosis by mitigating inflammatory storms and promoting cholesterol efflux
gan: Sijin Chen, et al.
Cyhoeddwyd: (2024-10-01)

Insulin-induced vascular redox dysregulation in human atherosclerosis is ameliorated by dipeptidyl peptidase 4 inhibition
gan: Akoumianakis, I, et al.
Cyhoeddwyd: (2020)

Insulin Treatment Induces Oxidative Stress in the Vascular Wall of Patients With Atherosclerosis Independently of Diabetes or Systemic Insulin Resistance: The Protective Role of DPP-IV Inhibition
gan: Akoumianakis, I, et al.
Cyhoeddwyd: (2018)

An immunoregulator nanomedicine approach for the treatment of tuberculosis
gan: Luona Yang, et al.
Cyhoeddwyd: (2023-05-01)

Challenges to Safe Nanomedicine Treatment
gan: Chunhua Yang, et al.
Cyhoeddwyd: (2023-03-01)

Biomarkers of premature atherosclerosis.
gan: Kampoli, A, et al.
Cyhoeddwyd: (2009)

Nanomedicine: Engineering of a tri-imageable nanoparticle for diagnostics
gan: Bumb, A, et al.
Cyhoeddwyd: (2009)

Prevention and Regression of Atherosclerosis: Emerging Treatments
gan: Aliosvi Rodríguez Rodríguez, et al.
Cyhoeddwyd: (2014-06-01)

Statins in coronary artery bypass grafting surgery: lipid lowering and beyond.
gan: Margaritis, M, et al.
Cyhoeddwyd: (2012)

The role of perivascular fat in the diagnosis and prognosis of atherosclerosis
gan: Polkinghorne, M, et al.
Cyhoeddwyd: (2022)

Homocysteine lowering: any use in atherosclerosis?
gan: Antoniades, C, et al.
Cyhoeddwyd: (2007)

Atorvastatin rapidly reduces myocardial superoxide and peroxynitrite generation in human atherosclerosis, by suppressing NADPH-oxidase activity independently of LDL lowering
gan: Antoniades, C, et al.
Cyhoeddwyd: (2011)

Nanomedicine Explored at Molecular Imaging Summit
gan: Julie L. Sutcliffe PhD
Cyhoeddwyd: (2011-01-01)

The Role of Optical Imaging in Translational Nanomedicine
gan: Evelien Hesemans, et al.
Cyhoeddwyd: (2022-08-01)

Advances in nanomedicines for lymphatic imaging and therapy
gan: Pan He, et al.
Cyhoeddwyd: (2023-08-01)

Nanomedicine for Imaging and Therapy of Pancreatic Adenocarcinoma
gan: Giulia Brachi, et al.
Cyhoeddwyd: (2019-11-01)

Perivascular adipose tissue and coronary atherosclerosis
gan: Mancio, J, et al.
Cyhoeddwyd: (2018)